Iu C, Clinical Research Excellence Application and Research Center

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Gastric and oesophageal cancer1 trial
• Lung cancer1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• BeiGene2 trials

Closed trials

• Completed

  Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma

  NCT03777657· Phase 3· BeiGene· Source

• Completed

  Comparison of Efficacy and Safety of Tislelizumab (BGB-A317) Versus Docetaxel as Treatment in the Second- or Third-line Setting in Participants With Non-Small Cell Lung Cancer (NSCLC)

  NCT03358875· Phase 3· BeiGene· Source